Stuck on a low-immunogenicity target?
Preview text: Stuck on a low-immunogenicity target? 96 Why rabbit monoclonals might be the key to…
Image not available
No image available for this email.
- Subject
- Stuck on a low-immunogenicity target?
- Preview text
- Stuck on a low-immunogenicity target? 96 Why rabbit monoclonals might be the key to…
- From
- marketing@
antibody.com - Brand
- Antibody Solutions
- ESP
- HubSpot
- Sent
- Mon Mar 16, 2026, 2:06 PM ET
- Size
- 57 KB
- Images
- 5
- Links
- 9, 1 of them buttons
- Subject length
- 37 characters
Sent just before and after
| Jul 23, 2026 12:08 PM | Part 2: Exploring Antibody Discovery in 2026 | |
| Jun 24, 2026 3:56 PM | Optimize Your ADA Assay Development | |
| Jun 1, 2026 10:16 AM | A handy, three-minute recap of PEGS 2026 | |
| May 7, 2026 3:57 PM | Find your way to ” yes” in Ab discovery at PEGS 2026 | |
| Apr 29, 2026 11:33 AM | Now: A more efficient way to diverse, actionable antibody candidates | |
| Mar 19, 2026 2:26 PM | Part 1: The State of Antibody Discovery in 2026 | |
| Mar 16, 2026 2:06 PM | Stuck on a low-immunogenicity target? (this email) |
More from Antibody Solutions
All Antibody Solutions emailsNEW @ PEGS Europe: Capturing Ag-specific Abs from rabbit memory + plasma B cells
Nov 4, 2026 11:35 AM
Bi-specific antibody discovery: The right partner is closer than you think
Oct 28, 2026 1:01 PM
